Stargazer Pharmaceuticals Funding: $57M Raised, Series A
Stargazer Pharmaceuticals is based in Boston. It has raised $57M in total funding. Latest round: Series A.
Stargazer Pharmaceuticals funding overview
Stargazer Pharmaceuticals is based in Boston. Stargazer Pharmaceuticals has raised $57M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2020. The round record for Stargazer Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Novo Holdings, venBio Partners, Canaan Partners, Pontifax, Retinal Degeneration Fund. 5 distinct backers are named across the disclosed rounds.
Stargazer Pharmaceuticals at a glance
Total raised
$57M
Latest round
Series A
Latest round date
November 2020
Headquarters
Boston
Notable investors
Novo Holdings, venBio Partners, Canaan Partners, Pontifax, Retinal Degeneration Fund
Frequently asked about Stargazer Pharmaceuticals funding
How much has Stargazer Pharmaceuticals raised?
Stargazer Pharmaceuticals has raised $57M in total disclosed funding across the rounds on record.
Who has invested in Stargazer Pharmaceuticals?
Novo Holdings, venBio Partners, Canaan Partners, Pontifax, Retinal Degeneration Fund are named among the investors backing Stargazer Pharmaceuticals.
What was the latest Stargazer Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in November 2020.
Where is Stargazer Pharmaceuticals based?
Stargazer Pharmaceuticals is based in Boston.
When did Stargazer Pharmaceuticals last raise?
The last disclosed Stargazer Pharmaceuticals round closed in November 2020 at Series A.
Round data for Stargazer Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
Companies related to Stargazer Pharmaceuticals (36)
